Literature DB >> 21869716

Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.

Chao-Hua Chiu1, Yi-Chen Yeh, Ko-Han Lin, Yu-Chun Wu, Yu-Chin Lee, Teh-Ying Chou, Chun-Ming Tsai.   

Abstract

INTRODUCTION: Previous studies have shown that lung squamous cell carcinoma has higher ¹⁸F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) than adenocarcinoma. We hypothesized that histological subtypes of lung adenocarcinoma were also different in ¹⁸F-FDG uptake.
METHODS: Patients who had preoperative PET/computed tomography (CT) scan and had undergone complete resection for lung adenocarcinoma between April 2007 and December 2009 were enrolled in this study. Because of the limitation of spatial resolution on PET/CT, tumors less than 1 cm were excluded for analysis. Two independent classification systems were used to categorize histological subtypes of adenocarcinoma; one was modified from the current World Health Organization classification and the other used the morphological features of the terminal respiratory unit (TRU). The maximal standardized uptake value (SUVmax) on PET/CT and the glucose transporter type 1 (GLUT-1) expression of the tumors were measured and correlated to the histology of lung adenocarcinoma.
RESULTS: One hundred fifty-two patients with 153 primary lung adenocarcinomas were included. There was a significant difference in SUVmax among different histological subtypes. Namely, solid predominant adenocarcinomas had significantly higher SUVmax than those with other predominant histology (p < 0.001), and TRU-type adenocarcinomas had significantly lower SUVmax than non-TRU-type adenocarcinomas (p < 0.001). Consistently, GLUT-1 expression was higher in tumors with a solid growth pattern than those without (p < 0.001) and in tumors with non-TRU type than TRU type (p < 0.001).
CONCLUSIONS: The histological subtypes of lung adenocarcinomas differ in GLUT-1 expression and ¹⁸F-FDG uptake on the PET/CT scan, suggesting that histological subtyping not only has morphological but also biological implications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21869716     DOI: 10.1097/JTO.0b013e318226b677

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  18 in total

Review 1.  Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).

Authors:  Elizabeth R Tang; Andrew M Schreiner; Bradley B Pua
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients.

Authors:  Duilio Divisi; Mirko Barone; Luca Bertolaccini; Gaetano Rocco; Piergiorgio Solli; Roberto Crisci
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients.

Authors:  J M González de Aledo-Castillo; S Casanueva-Eliceiry; A Soler-Perromat; D Fuster; V Pastor; N Reguart; N Viñolas; R Reyes; I Vollmer; P Paredes; J A Puig-Butillé
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-02       Impact factor: 9.236

4.  Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China.

Authors:  Xiaoyan Sun; Tianxiang Chen; Chun Xie; Liu Liu; Bei Lei; Lihua Wang; Maomei Ruan; Hui Yan; Qi Zhang; Cheng Chang; Wenhui Xie
Journal:  BMJ Open       Date:  2022-05-17       Impact factor: 3.006

5.  FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value.

Authors:  Marina Suárez-Piñera; José Belda-Sanchis; Alvaro Taus; Albert Sánchez-Font; Antoni Mestre-Fusco; Marcel Jiménez; Lara Pijuan
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

6.  Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma.

Authors:  Haichuan Hu; Yunjian Pan; Yuan Li; Lei Wang; Rui Wang; Yang Zhang; Hang Li; Ting Ye; Yiliang Zhang; Xiaoyang Luo; Longlong Shao; Zhengliang Sun; Deng Cai; Jie Xu; Qiong Lu; Youjia Deng; Lei Shen; Hongbin Ji; Yihua Sun; Haiquan Chen
Journal:  Onco Targets Ther       Date:  2014-08-13       Impact factor: 4.147

7.  Value of combining serum carcinoembryonic antigen and PET/CT in predicting EGFR mutation in non-small cell lung cancer.

Authors:  Jincui Gu; Siqi Xu; Lixia Huang; Shaoli Li; Jian Wu; Junwen Xu; Jinlun Feng; Baomo Liu; Yanbin Zhou
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

8.  The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients.

Authors:  Deniz Koksal; Funda Demirag; Hulya Bayiz; Ozlem Ozmen; Ebru Tatci; Bahadir Berktas; Koray Aydoğdu; Erdal Yekeler
Journal:  J Cardiothorac Surg       Date:  2013-04-04       Impact factor: 1.637

9.  Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer.

Authors:  Dong Soo Lee; Seung Joon Kim; Hong Seok Jang; Ie Ryung Yoo; Kyung Ran Park; Sae Jung Na; Kyo Young Lee; Sook Hee Hong; Jin Hyoung Kang; Young Kyoon Kim; Yeon Sil Kim
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

10.  Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis.

Authors: 
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.